1. Home
  2. MDXG vs MSEX Comparison

MDXG vs MSEX Comparison

Compare MDXG & MSEX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
  • MSEX
  • Stock Information
  • Founded
  • MDXG 2006
  • MSEX 1897
  • Country
  • MDXG United States
  • MSEX United States
  • Employees
  • MDXG N/A
  • MSEX N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • MSEX Water Supply
  • Sector
  • MDXG Health Care
  • MSEX Utilities
  • Exchange
  • MDXG Nasdaq
  • MSEX Nasdaq
  • Market Cap
  • MDXG 877.4M
  • MSEX 933.6M
  • IPO Year
  • MDXG N/A
  • MSEX N/A
  • Fundamental
  • Price
  • MDXG $7.02
  • MSEX $53.04
  • Analyst Decision
  • MDXG Strong Buy
  • MSEX Buy
  • Analyst Count
  • MDXG 2
  • MSEX 4
  • Target Price
  • MDXG $12.00
  • MSEX $61.00
  • AVG Volume (30 Days)
  • MDXG 1.0M
  • MSEX 184.8K
  • Earning Date
  • MDXG 07-30-2025
  • MSEX 07-31-2025
  • Dividend Yield
  • MDXG N/A
  • MSEX 2.56%
  • EPS Growth
  • MDXG N/A
  • MSEX 17.05
  • EPS
  • MDXG 0.21
  • MSEX 2.41
  • Revenue
  • MDXG $363,774,000.00
  • MSEX $195,831,000.00
  • Revenue This Year
  • MDXG $9.55
  • MSEX $6.54
  • Revenue Next Year
  • MDXG $11.43
  • MSEX $7.47
  • P/E Ratio
  • MDXG $33.21
  • MSEX $22.02
  • Revenue Growth
  • MDXG 6.85
  • MSEX 11.91
  • 52 Week Low
  • MDXG $5.47
  • MSEX $48.18
  • 52 Week High
  • MDXG $10.14
  • MSEX $70.73
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 55.25
  • MSEX 47.18
  • Support Level
  • MDXG $6.91
  • MSEX $51.44
  • Resistance Level
  • MDXG $7.37
  • MSEX $53.78
  • Average True Range (ATR)
  • MDXG 0.33
  • MSEX 1.37
  • MACD
  • MDXG 0.02
  • MSEX 0.15
  • Stochastic Oscillator
  • MDXG 36.18
  • MSEX 51.23

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

About MSEX Middlesex Water Company

Middlesex Water Co owns and operates regulated water utility and wastewater systems in the U.S. The firm operates in the eastern states of New Jersey, Delaware, and Pennsylvania. The company has two operating segments, Regulated and Non-Regulated. The regulated business includes collecting and distributing water to residential, commercial, industrial, and fire protection consumers. The non-regulated business includes contract services for the operation of private water and wastewater systems. The majority of the company's revenue is derived from the Regulated segment and from residential customers.

Share on Social Networks: